camlipixant

News

Three years after buying Bellus Health and its chronic cough candidate camlipixant for around $2 billion, GSK is abandoning the programme.

News

MSD will have to return to the drawing board to chart a course for US approval of its chronic cough treatment gefapixant.

News

In a first for consumer wearables, Google has introduced a feature on Pixel Watch and Fitbit Air devices that it says can monitor insulin resistance.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.